Results 211 to 220 of about 89,230 (317)

Phenotypic patterns of metabolic dysfunction‐associated steatotic liver disease in type 2 diabetes: The impact of insulin

European Journal of Clinical Investigation, EarlyView.
Abstract Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) often leads to hepatic insulin resistance (IR), yet its link to liver‐specific insulin‐mediated glucose uptake (IGLU) in type 2 diabetes (T2D) remains unclear. We aimed to explore this MASLD‐T2D relationship, addressing organ‐specific IR for personalized management and
Queralt Martín‐Saladich, Rafael Simó, Andreea Ciudin, Julia Baguña, Clara Ramirez‐Serra, Santiago Aguadé‐Bruix, Albert Roque, Maria N. Pizzi, Hug Cuéllar, Nuria Roson‐Gradaille, Miguel A. González Ballester, Juan M. Pericàs, José Raul Herance   +12 more
wiley   +1 more source

An Infiltrative Case of Angiosarcoma Causing Portal Hypertension. [PDF]

ACG Case Rep J
Bae G, Dunleavy KA, Hagen C, Simonetto DA, Abdelmalek MF.   +4 more
europepmc   +1 more source

Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation

European Journal of Clinical Investigation, EarlyView.
This consensus highlights critical research gaps in obesity epidemiology, phenotypic heterogeneity and clinical management, calling for advanced methodologies, collaborative strategies and innovative policies to mitigate the global obesity epidemic and its socio‐economic impacts.
Federico Carbone, Jean‐Pierre Després, John P. A. Ioannidis, Ian J. Neeland, Gabriella Garruti, Luca Busetto, Luca Liberale, Stefano Ministrini, Gemma Vilahur, Thomas H. Schindler, Maria Paula Macedo, Agostino Di Ciaula, Marcin Krawczyk, Andreas Geier, Gyorgy Baffy, Maria Felicia Faienza, Ilaria Farella, Nicola Santoro, Gema Frühbeck, Patricia Yárnoz‐Esquiroz, Javier Gómez‐Ambrosi, Emma Chávez‐Manzanera, Verónica Vázquez‐Velázquez, Jean‐Michel Oppert, Dimitrios N. Kiortsis, Paolo Sbraccia, Carmine Zoccali, Piero Portincasa, Fabrizio Montecucco   +28 more
wiley   +1 more source

Cirrhotic portal hypertension: Morbidity of continued alcoholism

, 1978
Narayan V. Pande, Robert H. Resnick, William F. H. Yee, Volker F. Eckardt, Jonathan L. Shurberg   +4 more
openalex   +1 more source

Portal hypertension aggravates Helicobacter pylori induced liver injury in mice via activating pyroptosis pathway. [PDF]

Sci Rep
Hu J, Gao L, Maswikiti EP, Li X, Gu B, Yu Y, Li H, Chen H.   +7 more
europepmc   +1 more source

The Surgery of Portal Hypertension [PDF]

Postgraduate Medical Journal, 1950
openaire   +4 more sources

Autoimmunity in MASLD: Focus on autoantibodies, anti‐apolipoprotein A1 IgG and G protein‐coupled receptors

European Journal of Clinical Investigation, EarlyView.
This review outlines the potential role of anti‐GPCR autoantibodies in MASLD/MASH, given their involvement in a wide range of diseases and their possible contribution to MASLD/MASH pathophysiology. We also focused on anti‐ApoA1 autoantibodies, sharing functional features with anti‐GPCR autoantibodies and have been shown to promote liver steatosis in ...
Sabrina Pagano, Emmanuel Somm, François R. Jornayvaz, Nicolas Vuilleumier   +3 more
wiley   +1 more source

Hereditary Hemorrhagic Telangiectasia Presenting With Portal Hypertension and Cirrhosis of the Liver

, 1972
O Feizi
openalex   +1 more source

Inflammation remains a dynamic component of portal hypertension in regressive alcohol-related cirrhosis. [PDF]

United European Gastroenterol J
Hofer BS, Simbrunner B, Königshofer P, Brusilovskaya K, Petrenko O, Taru V, Sorz-Nechay T, Zinober K, Regnat K, Semmler G, Lackner C, Trauner M, Mandorfer M, Schwabl P, Reiberger T.   +14 more
europepmc   +1 more source

Portal Hypertension [PDF]

Proceedings of the Royal Society of Medicine, 1963
openaire   +3 more sources